Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females

American Journal of Hypertension

Volumn 26, Issue 2, 2013, Pages 250-256

  Lambert, Elisabeth ^a,b   Straznicky, Nora ^a   Sari, Carolina Ika ^a   Eikelis, Nina ^a   Hering, Dagmara ^a,c   Head, Geoffrey ^a,b   Dixon, John ^a,b   Esler, Murray ^a,b   Schlaich, Markus ^a,b   Lambert, Gavin ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

blood pressure; C reactive protein; cholesterol; endothelial function; hypertension; sympathetic nervous system

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPEREMIA; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPATHETIC FUNCTION;

AGE FACTORS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM; YOUNG ADULT;

EID: 84876520860     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hps016     Document Type: Article

References (41)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
2. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-234. (Pubitemid 20226996)
3. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36: 103-109. (Pubitemid 30466119)
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
5. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010;31:1142-1148.
6. Harris KF, Matthews KA. Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom Med 2004;66:153-164. (Pubitemid 38393223)
7. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, Chopra R, Wong C, Chatzivlastou K, Head G, Straznicky N, Esler M, Schlaich M, Lambert G. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010;56:351-358.
8. Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998;29:1116-1121. (Pubitemid 28265464)
9. Adel A, Abdel-Salam Z, Nammas W. Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study. J Clin Hypertens (Greenwich) 2010;12:820-825.
10. Sinski M, Lewandowski J, Ciarka A, Bidiuk J, Abramczyk P, Dobosiewicz A, Gaciong Z. Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension. Kardiol Pol 2009;67:613-620.
11. Vaddadi G, Guo L, Esler M, Socratous F, Schlaich M, Chopra R, Eikelis N, Lambert G, Trauer T, Lambert E. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol 2011;4:711-718.
12. Lambert E, d'Udekem Y, Cheung M, Sari CI, Inman J, Ahimastos A, Eikelis N, Pathak A, King I, Grigg L, Schlaich M, Lambert G. Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol 2012. [Epub ahead of print.]
13. Womersley J. A comparison of the skinfold method with extent of 'overweight' and various weight-height relationships in the assessment of obesity. Br J Nutr 1977;38:271-284. (Pubitemid 8181102)
14. Fagius J, Wallin BG. Sympathetic reflex latencies and conduction velocities in normal man. J Neurol Sci 1980;47:433-448. (Pubitemid 10059360)
15. Parati G, Frattola A, Di Rienzo M, Castiglioni P, Pedotti A, Mancia G. Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol 1995;268:H1606-1612.
16. Jones PP, Snitker S, Skinner JS, Ravussin E. Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol 1996;270:E363-366.
17. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 1997;96:3287-3293. (Pubitemid 27513396)
18. Julius S, Nesbitt SD. Sympathetic nervous system as a coronary risk factor in hypertension. Cardiologia 1996;41:309-317.
19. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 2006;29:839-847. (Pubitemid 46062115)
20. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257-1263.
21. Li J, Zhao S, Li X. [Non-invasive detection of endothelial dependent dilatation dysfunction in patients with essential hypertension]. Hunan Yi Ke Da Xue Xue Bao 1998;23:590-592, 595.
22. Weil BR, Stauffer BL, Mestek ML, Desouza CA. Influence of abdominal obesity on vascular endothelial function in overweight/obese adult men. Obesity (Silver Spring) 2011;19:1742-1746.
23. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69:1596-1601.
24. Owlya R, Vollenweider L, Trueb L, Sartori C, Lepori M, Nicod P, Scherrer U. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation 1997;96:3897-3903.
25. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol 2002;39:683-688. (Pubitemid 34158166)
26. Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord 1999;23:801-809. (Pubitemid 29378254)
27. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913-917. (Pubitemid 28255665)
28. Marinari GM, Scopinaro N, Adami GF. Leptin and HDL-cholesterol in non-diabetic normotensive subjects. Obes Surg 2001;11:252-253. (Pubitemid 32607210)
29. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999;13:1231-1238. (Pubitemid 29300368)
30. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65. (Pubitemid 28060271)
31. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002;39:496-501. (Pubitemid 34165172)
32. Niskanen L, Laaksonen DE, Nyyssonen K, Punnonen K, Valkonen VP, Fuentes R, Tuomainen TP, Salonen R, Salonen JT. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004;44:859-865. (Pubitemid 39577412)
33. Spruijt-Metz D, Emken BA, Spruijt MR, Richey JM, Berman LJ, Belcher BR, Hsu YW, McClain AD, Lane CJ, Weigensberg MJ. CRP is related to higher leptin levels in minority peripubertal females regardless of adiposity levels. Obesity (Silver Spring) 2012;20:512-516.
34. Tremblay J. Genetic determinants of C-reactive protein levels in metabolic syndrome: a role for the adrenergic system J Hypertens 2007;25:281-283. (Pubitemid 46071923)
35. Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 2009;206:61-68.
36. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens 2003;17:223-230. (Pubitemid 36592013)
37. Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009;89:27-36.
38. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997;10:77-83. (Pubitemid 27038975)
39. Williams MR, Westerman RA, Kingwell BA, Paige J, Blombery PA, Sudhir K, Komesaroff PA. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001;86:5389-5395. (Pubitemid 33070265)
40. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 2000;101: 862-868. (Pubitemid 30117881)
41. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Jr., Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004;44:2137-2141. (Pubitemid 39576032)